Discussion	O

Because	O
Netherton	O
syndrome	O
exhibits	O
allergic	O
phenotype	O
,	O
it	O
is	O
reasonable	O
to	O
speculate	O
that	O
SPINK5	O
,	O
which	O
is	O
mutated	O
in	O
Netherton	O
syndrome	O
,	O
may	O
act	O
as	O
a	O
candidate	O
gene	O
for	O
asthma	O
and	O
other	O
allergic	O
diseases	O
[	O
9	O
]	O
.	O

An	O
extensive	O
search	O
for	O
single	O
nucleotide	O
polymorphisms	O
in	O
the	O
SPINK5	O
led	O
to	O
the	O
identification	O
of	O
a	O
number	O
of	O
SNPs	O
,	O
including	O
six	O
nonsynonymous	O
SNPs	O
in	O
coding	O
region	O
that	O
might	O
perturb	O
its	O
immune	O
function	O
.	O

Subsequent	O
genotyping	O
of	O
three	O
nonsynonymous	O
SNPs	O
,	O
A1103G	O
,	O
G1156A	O
and	O
G1258A	O
in	O
two	O
independent	O
panels	O
of	O
British	O
families	O
showed	O
a	O
significant	O
association	O
between	O
SNP	O
G1258A	O
(	O
Glu420Lys	O
)	O
and	O
atopy	O
,	O
atopic	O
dermatitis	O
,	O
elevated	O
serum	B-Organism_substance
IgE	O
levels	O
and	O
asthma	O
[	O
10	O
]	O
.	O

This	O
association	O
was	O
confirmed	O
in	O
a	O
large	O
German	O
population	O
and	O
two	O
Japanese	O
populations	O
[	O
16	O
-	O
18	O
]	O
.	O

Kato	O
et	O
al	O
analyzed	O
eight	O
SNPs	O
in	O
exon	O
13	O
and	O
14	O
of	O
the	O
SPINK5	O
including	O
G1258A	O
(	O
Glu420Lys	O
)	O
,	O
and	O
found	O
a	O
positive	O
association	O
of	O
seven	O
SNPs	O
with	O
atopic	O
dermatitis	O
in	O
a	O
Japanese	O
study	O
sample	O
using	O
a	O
case	O
-	O
control	O
study	O
design	O
[	O
16	O
]	O
.	O

Nishio	O
et	O
al	O
surveyed	O
five	O
of	O
six	O
previously	O
reported	O
nonsynonymous	O
SPINK5	O
SNPs	O
in	O
Japanese	O
atopic	O
families	O
identified	O
through	O
asthmatic	O
children	O
or	O
subjects	O
with	O
atopic	O
dermatitis	O
and	O
found	O
that	O
SPINK5	O
was	O
associated	O
with	O
development	O
of	O
atopic	O
dermatitis	O
but	O
not	O
asthma	O
[	O
17	O
]	O
.	O

Kabesch	O
M	O
et	O
al	O
.	O
analyzed	O
G1258A	O
(	O
Glu420Lys	O
)	O
in	O
a	O
German	O
population	O
of	O
school	O
children	O
,	O
and	O
found	O
its	O
association	O
with	O
asthma	O
as	O
well	O
as	O
a	O
concomitant	O
occurrence	O
of	O
asthma	O
and	O
atopic	O
dermatitis	O
[	O
18	O
]	O
.	O

However	O
,	O
two	O
subsequent	O
studies	O
failed	O
to	O
replicate	O
the	O
original	O
SPINK5	O
findings	O
for	O
allergic	O
diseases	O
[	O
19	O
,	O
20	O
]	O
.	O

Folster	O
-	O
Holst	O
et	O
al	O
genotyped	O
four	O
nonsynonymous	O
SNPs	O
(	O
Asp106Asn	O
,	O
Asn368Ser	O
,	O
Asp386Asn	O
,	O
and	O
Glu420Lys	O
)	O
,	O
and	O
detected	O
no	O
association	O
between	O
SPINK5	O
and	O
atopic	O
dermatitis	O
in	O
populations	O
of	O
Northern	O
German	O
origin	O
[	O
20	O
]	O
.	O

Jongepier	O
H	O
et	O
al	O
.	O
failed	O
to	O
detect	O
any	O
association	O
between	O
SPINK5	O
and	O
asthma	O
,	O
atopic	O
phenotypes	O
and	O
atopic	O
dermatitis	O
in	O
a	O
Dutch	O
population	O
[	O
19	O
]	O
.	O

These	O
discordant	O
findings	O
probably	O
reflect	O
different	O
genetic	O
and	O
environmental	O
backgrounds	O
in	O
various	O
populations	O
.	O

To	O
determine	O
whether	O
nonsynonymous	O
SNPs	O
of	O
the	O
SPINK5	O
are	O
involved	O
in	O
the	O
pathogenesis	O
of	O
asthma	O
in	O
the	O
Chinese	O
Han	O
population	O
,	O
we	O
performed	O
a	O
case	O
-	O
control	O
study	O
by	O
genotyping	O
four	O
nonsynonymous	O
SNPs	O
in	O
the	O
SPINK5	O
.	O

We	O
did	O
not	O
detect	O
any	O
significant	O
association	O
between	O
these	O
nonsynonymous	O
SNPs	O
and	O
asthma	O
in	O
our	O
Chinese	O
samples	O
.	O

With	O
our	O
sample	O
size	O
,	O
we	O
expected	O
a	O
power	O
of	O
at	O
least	O
80	O
%	O
in	O
detecting	O
an	O
effect	O
of	O
OR	O
>	O
=	O
1	O
.	O
3	O
for	O
each	O
of	O
these	O
SNPs	O
.	O

Therefore	O
,	O
our	O
failure	O
to	O
detect	O
an	O
association	O
for	O
these	O
4	O
SNPs	O
was	O
not	O
due	O
to	O
the	O
sample	O
size	O
.	O

These	O
results	O
suggest	O
that	O
the	O
polymorphisms	O
in	O
the	O
coding	O
region	O
of	O
the	O
SPINK5	O
are	O
unlikely	O
to	O
contribute	O
to	O
asthma	O
risk	O
in	O
the	O
Chinese	O
Han	O
population	O
.	O

However	O
,	O
because	O
our	O
patients	O
were	O
ascertained	O
for	O
asthma	O
,	O
we	O
could	O
not	O
exclude	O
a	O
role	O
of	O
the	O
coding	O
SNPs	O
of	O
the	O
SPINK5	O
in	O
atopic	O
dermatitis	O
in	O
our	O
population	O
.	O

The	O
variations	O
in	O
the	O
regulatory	O
sequences	O
of	O
genes	O
may	O
determine	O
risks	O
to	O
common	O
diseases	O
by	O
causing	O
different	O
levels	O
of	O
expression	O
.	O

Therefore	O
,	O
the	O
identification	O
and	O
functional	O
evaluation	O
of	O
polymorphisms	O
in	O
promoter	O
region	O
are	O
of	O
great	O
value	O
in	O
understanding	O
the	O
genetic	O
susceptibility	O
to	O
asthma	O
.	O

In	O
order	O
to	O
determine	O
the	O
role	O
of	O
the	O
SPINK5	O
promoter	O
polymorphism	O
in	O
the	O
pathogenesis	O
of	O
asthma	O
,	O
we	O
genotyped	O
a	O
promoter	O
polymorphism	O
,	O
-	O
206G	O
>	O
A	O
,	O
in	O
422	O
asthma	O
patients	O
and	O
410	O
controls	O
,	O
and	O
found	O
a	O
marginal	O
association	O
.	O

The	O
frequency	O
of	O
allele	O
G	O
was	O
significantly	O
higher	O
in	O
asthmatic	O
patients	O
than	O
that	O
in	O
controls	O
(	O
p	O
=	O
0	O
.	O
022	O
)	O
.	O

To	O
confirm	O
the	O
association	O
,	O
additional	O
267	O
asthma	O
patients	O
and	O
301	O
controls	O
newly	O
recruited	O
from	O
the	O
same	O
hospital	O
were	O
genotyped	O
,	O
and	O
the	O
-	O
206G	O
>	O
A	O
polymorphism	O
remained	O
significantly	O
associated	O
with	O
asthma	O
(	O
P	O
=	O
0	O
.	O
001	O
)	O
,	O
even	O
after	O
Bonferroni	O
correction	O
(	O
adjusted	O
P	O
=	O
0	O
.	O
01	O
)	O
.	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
an	O
association	O
of	O
-	O
206G	O
>	O
A	O
polymorphism	O
with	O
asthma	O
.	O

We	O
further	O
examined	O
the	O
potential	O
functional	O
role	O
of	O
this	O
promoter	O
polymorphism	O
,	O
and	O
found	O
that	O
the	O
G	O
to	O
A	O
substitution	O
at	O
-	O
206	O
generated	O
a	O
GATA	O
-	O
3	O
transcription	O
factor	O
binding	O
site	O
.	O

Major	O
transcription	O
factors	O
controlling	O
Th1	O
and	O
Th2	O
development	O
,	O
such	O
as	O
T	O
-	O
box	O
transcription	O
factor	O
and	O
GATA3	O
,	O
are	O
possibly	O
involved	O
in	O
asthma	O
and	O
atopic	O
diseases	O
.	O

GATA	O
-	O
3	O
,	O
a	O
transcription	O
factor	O
specifically	O
expressed	O
in	O
T	B-Cell
helper	I-Cell
2	I-Cell
(	I-Cell
Th2	I-Cell
)	I-Cell
cells	I-Cell
,	O
plays	O
a	O
critical	O
role	O
in	O
the	O
differentiation	O
of	O
Th2	B-Cell
cells	I-Cell
from	O
uncommitted	O
CD4	B-Cell
+	I-Cell
lymphocytes	I-Cell
.	O

In	O
addition	O
,	O
GATA	O
-	O
3	O
is	O
essential	O
for	O
the	O
expression	O
of	O
the	O
cytokines	O
IL	O
-	O
4	O
,	O
IL	O
-	O
5	O
and	O
IL	O
-	O
13	O
that	O
mediate	O
allergic	O
inflammation	O
[	O
23	O
]	O
.	O

Our	O
luciferase	O
reporter	O
assay	O
confirmed	O
that	O
SNP	O
-	O
206G	O
>	O
A	O
is	O
associated	O
with	O
the	O
transcriptional	O
activity	O
of	O
SPINK5	O
.	O

The	O
G	O
allele	O
was	O
associated	O
with	O
decreased	O
transcriptional	O
activity	O
of	O
the	O
SPINK5	O
.	O

The	O
mechanism	O
by	O
which	O
the	O
-	O
206G	O
>	O
A	O
SNP	O
affects	O
SPINK5	O
expression	O
may	O
be	O
explained	O
by	O
the	O
potential	O
differential	O
transcription	O
factor	O
binding	O
of	O
GATA	O
binding	O
factor	O
,	O
since	O
-	O
206G	O
>	O
A	O
is	O
located	O
at	O
the	O
core	O
sequence	O
of	O
GATA	O
binding	O
factor	O
binding	O
site	O
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
confirmed	O
that	O
the	O
A	O
to	O
G	O
substitution	O
at	O
-	O
206	O
significantly	O
reduced	O
the	O
binding	O
efficiency	O
of	O
nuclear	B-Cellular_component
proteins	O
to	O
this	O
element	O
.	O

Our	O
data	O
suggest	O
that	O
loss	O
of	O
GATA	O
transcription	O
factor	O
regulation	O
with	O
the	O
-	O
206G	O
may	O
decrease	O
the	O
SPINK5	O
expression	O
and	O
thereby	O
potentially	O
perturb	O
the	O
immunosuppressive	O
function	O
of	O
LEKTI	O
.	O

